Company News
Tuesday, February 28, 2017
BRIEF-Amgen announces positive results from planned overall survival analysis of phase 3 head-to-head ENDEAVOR trial
* Announces positive results from planned overall survival
analysis of phase 3 head-to-head ENDEAVOR trial
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment